Transdermal device for the delivery of testosterone
February 27, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesTransdermal monolith systems Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels Subsaturated transdermal drug delivery device exhibiting enhanced drug flux Contraceptive methods and formulations for use therein Transdermal pentamidine Percutaneously absorbable compositions of morphine or analogous analgesics of morphine Methods and formulations for use in treating oophorectomized women Methods for providing testosterone and optionally estrogen replacement therapy to women Transdermal therapeutic systems with crystallization inhibitors Process of assembling a transdermal patch incorporating a polymer film incorporated with an active agent InventorsApplicationNo. 031619 filed on 02/27/1998US Classes:424/448, Pressure sensitive adhesive means424/449Transdermal or percutaneousExaminersPrimary: Page, Thurman K.Assistant: Ware, Todd D Attorney, Agent or FirmForeign Patent References
International ClassesA61F 013/02A61F 013/00 AbstractA transdermal delivery device including an adhesive layer that contains a therapeutically effective amount of testosterone and a delivery enhancing adjuvant comprising a terpene.Other References
| |
